HER2-Low and Ultralow Metastatic Breast Cancer: Evolving Definitions, Emerging Evidence, and Shifting Treatment Paradigms

Join us for a timely and informative webinar on HER2-Low and Ultralow Metastatic Breast Cancer: Evolving Definitions, Emerging Evidence, and Shifting Treatment Paradigms, featuring internationally recognized breast medical oncologist Dr. Neil Iyengar, who will share the latest insights and clinical trial data shaping global practice. Providing the Canadian perspective is Dr. Nicholas Meti, a respected clinician in the breast cancer field, who will moderate the session and highlight how these advances are being applied in Canadian care settings. Don't miss this opportunity to gain expert guidance on navigating the evolving landscape of HER2-low and ultralow disease.

This activity has been funded by an educational grant from AstraZeneca and Daiichi Sankyo and is intended for healthcare practitioners only.